Skip to content

Author

Jose A. Ovando-Ricardez

We have 1 of 10 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

TLSB-25 SINGLE-CELL CHARACTERIZATION OF RENAL CELL CARCINOMA BRAIN METASTASIS

RCC BM represents a biologically distinct tumor entity shaped by neural adaptation, metabolic reprogramming, and immune dysfunction, and supported clinical trials approval testing lenvatinib plus pembrolizumab and zanzalitinib in RCC BM patients.

M. I. Ali, Z. Akpinar, Jose A. Ovando-Ricardez et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.